By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – Abbott today reported that its fourth-quarter molecular diagnostics sales increased 21 percent year over year.

Abbott's total diagnostics sales were $1.02 billion for the quarter, up 4 percent year over year.

Its molecular diagnostics sales contributed $114 million to that total and were up 21 percent. Its US molecular diagnostics sales were $55 million, up 32 percent, and its international sales were up roughly 13 percent at $59 million.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.